The current staging system for non-small cell lung cancer (NSCLC) is tumor-node-metastasis (TNM) staging,(2) which provides only a definition of the anatomic extent of the neoplasia: size, location, and extent of the primary lesion; presence and location of the locoregional lymph node metastasis; and systemic metastatic disease.